Zegfrovy

sunvozertinib

How do you pay?

What you’d pay without insurance.

How to pay the least

Ask for the cash price

Zegfrovy

We didn’t find one.

  1. Ask your pharmacy for Zegfrovy’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameZegfrovy
Authorized genericsunvozertinib
Regular genericsunvozertinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one.
Not soldWe didn’t find one.
Same as Zegfrovy?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Zegfrovy’s maker. Ask the pharmacy for Zegfrovy’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Zegfrovy itself, from the same company, sold without the brand name, and usually for less. For now Zegfrovy is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Zegfrovy’s cash price, or your plan what it charges.

What it’s used for

In the words of its FDA label:

ZEGFROVY is indicated for the treatment of adult patients with locally advanced or metastatic nonsmall cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).

Source: the FDA label for Zegfrovy (Dizal), July 2, 2025. Full label from the FDA (PDF) 

Good to know